These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4628933)

  • 1. [Experimental pharmacological studies in the development of disodium cromoglycate].
    Cox JS
    Alergia; 1972 Aug; 20(1):35-46. PubMed ID: 4628933
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiallergic activity of alkyl substituted pyrazolo[3, 4-d]pyrimidine (compound 88-765).
    Gupta PP; Srimal RC; Avasthi K; Garg N; Chandra T; Bhakuni DS
    Indian J Exp Biol; 1995 Jan; 33(1):38-40. PubMed ID: 9135673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRL 22321, a compound that has mast cell stabilizing activity similar to that of disodium cromoglycate and in addition has smooth muscle relaxing activity.
    Spicer BA; Ross JW; Clarke GD; Harling EJ; Hassall PA; Smith H; Taylor JF
    Agents Actions; 1983 Jun; 13(4):301-9. PubMed ID: 6193695
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of ascorbic acid and disodium cromoglycate in some models of experimental anaphylaxis.
    González RG; García M; Pérez Saad H; de la Vega AR
    Allergol Immunopathol (Madr); 1979; 7(3):211-6. PubMed ID: 89807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY; Kim JS; An NH; Park RK; Kim HM
    Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells.
    Kusner EJ; Dubnick B; Herzig DJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):41-6. PubMed ID: 4119619
    [No Abstract]   [Full Text] [Related]  

  • 8. The anti-anaphylactic actions of disodium cromoglycate, theophylline, isoprenaline and prostaglandins.
    Taylor WA; Francis DH; Sheldon D; Roitt IM
    Int Arch Allergy Appl Immunol; 1974; 46(1):104-20. PubMed ID: 4360669
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the survival of in-vitro cultivated rat peritoneal mast cells in presence of disodium cromoglycate].
    Baeckeland E
    C R Seances Soc Biol Fil; 1972; 166(4):727-30. PubMed ID: 4631302
    [No Abstract]   [Full Text] [Related]  

  • 10. Disodium cromoglycate in immunological mast cell degranulation of mice: an experimental study.
    Goldgraber MB
    Ann Allergy; 1976 Aug; 37(2):123-5. PubMed ID: 823844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disodium cromoglycate and degranulation of rat peritoneal mast cells induced by 48-80].
    Baeckeland E; Lecomte J
    C R Seances Soc Biol Fil; 1972; 166(1):218-20. PubMed ID: 4118285
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological studies on some anaphylactic reactions in mice.
    Pleczarska A
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):779-84. PubMed ID: 4155938
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of disodium cromoglycate action on mast cell degranulation and on heparin release induced by lipid suspension].
    Guillosson JJ; Nafziger J; Piette C; Piette M
    Ann Pharm Fr; 1982 Jul; 40(2):105-12. PubMed ID: 6814334
    [No Abstract]   [Full Text] [Related]  

  • 14. Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug.
    Cox JS
    Br J Dis Chest; 1971 Oct; 65(4):189-204. PubMed ID: 4400180
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the chronic toxicity of inhaled disodium cromoglycate in the squirrel monkey.
    Levinsky HV; MacFarland HN; Procter BG; Rona G; Blair AM
    Toxicol Appl Pharmacol; 1978 Jul; 45(1):141-53. PubMed ID: 99843
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Apr; 197(1):153-62. PubMed ID: 57234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
    Spicer BA; Ross JW; Smith H
    Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Jun; 197(3):725-33. PubMed ID: 58988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of predosage with disodium cromoglycate (DSCG) on the dose-related inhibition of rat passive cutaneous anaphylaxis by DSCG.
    Riley PA; Sheard P; Clarke AJ; Orr TS
    Life Sci; 1975 Sep; 17(5):793-802. PubMed ID: 813078
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative antiallergic and anti-inflammatory action of F1865, mepyramine maleate, desonide and disodium cromoglycate after cutaneous administration].
    Tarayre JP; Aliaga M; Villanova G; Barbara M; Bru M; Caillol V; Lauressergues H
    J Pharmacol; 1984; 15(1):37-51. PubMed ID: 6425568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.